Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus

Table 1

Patient demographics pretransplantation.

Variable	No. of patients
	Single MSCT	Double MSCT
	(𝑛=30)	(𝑛=28)
Age in years	30 (12–47)	33 (16–54)
Gender, 𝑛 (F/M)	25/5	26/2
Race, 𝑛 (Asian/others)	30/0	28/0
Disease duration (m)	62 (7–232)	92 (12–264)
MSCs source, 𝑛
Bone marrow (BM)	12	9
Umbilical cord (UC)	18	19
Medium followup for survivors (m)	27 (12–48)	26 (12–40)

MSCT, mesenchymal stem cells transplantation.